Dorotea Sciacca
Viagrande, 95029, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Beyond germ cell tumors: focus on Leydig cell neoplasms from a single-center experience.
Journal: Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
Published: May 12, 2025
An Unusual and Exaggerated Local Cutaneous Reaction Following Re-Irradiation and Fulvestrant Administration: A Clinical Conundrum.
Journal: Diagnostics (Basel, Switzerland)
Published: February 27, 2025
Sepsis detection in hematologic and solid tumor malignancies using quantitative inflammatory biomarker differences in a prospective single center study.
Journal: Scientific reports
Published: December 06, 2024
The Pivotal Role of Protein Phosphatase 2A (PP2A) in Brain Tumors.
Journal: International journal of molecular sciences
Published: November 25, 2022
Overview on Common Genes Involved in the Onset of Glioma and on the Role of Migraine as Risk Factor: Predictive Biomarkers or Therapeutic Targets?
Journal: Journal of personalized medicine
Published: October 13, 2022
Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis.
Journal: Frontiers in endocrinology
Published: October 09, 2022
Metabolic complete tumor response in a patient with epidermal growth factor receptor mutant non-small cell lung cancer treated with a reduced dose of afatinib.
Journal: The Journal of international medical research
Published: March 16, 2022
Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects.
Journal: Frontiers in endocrinology
Published: January 23, 2022
PD1/PD-L1 immune checkpoint as a potential target for preventing brain tumor progression.
Journal: Cancer immunology, immunotherapy : CII
Published: April 13, 2021
Role of the Combination of Cyclin-Dependent Kinase Inhibitors (CDKI) and Radiotherapy (RT) in the Treatment of Metastatic Breast Cancer (MBC): Advantages and Risks in Clinical Practice.
Journal: Frontiers in oncology
Published: December 17, 2020
Last Updated: 09/26/2026